Clinical features and outcome of primary effusion lymphoma in HIV-infected patients: a single-institution study.
about
Co-infections and Pathogenesis of KSHV-Associated MalignanciesEpstein-Barr Virus-associated lymphoproliferative disorders: experimental and clinical developmentsEvaluation of respiratory diseaseNEDDylation is essential for Kaposi's sarcoma-associated herpesvirus latency and lytic reactivation and represents a novel anti-KSHV targetUp-regulation of tumor suppressor genes by exogenous dhC16-Cer contributes to its anti-cancer activity in primary effusion lymphoma.Thoracic diseases associated with HIV infection in the era of antiretroviral therapy: clinical and imaging findings.Genomic analysis of xCT-mediated regulatory network: Identification of novel targets against AIDS-associated lymphoma.Targeting sphingosine kinase induces apoptosis and tumor regression for KSHV-associated primary effusion lymphoma.Targeting xCT, a cystine-glutamate transporter induces apoptosis and tumor regression for KSHV/HIV-associated lymphomaCooperative roles for emmprin and LYVE-1 in the regulation of chemoresistance for primary effusion lymphoma.Molecular mechanisms of activating c-MET in KSHV+ primary effusion lymphoma.Case 2-2011: a 34 year-old man with Fever and abdominal pain.Human Herpesvirus Type 8-associated Large B-cell Lymphoma: A Nonserous Extracavitary Variant of Primary Effusion Lymphoma in an HIV-infected Man: A Case Report and Review of the Literature.Efficacy of bortezomib in a direct xenograft model of primary effusion lymphomaDendritic cells: key players in human herpesvirus 8 infection and pathogenesis.Targeting the mammalian target of Rapamycin to inhibit VEGF and cytokines for the treatment of primary effusion lymphoma.Neoplastic pericardial disease: Old and current strategies for diagnosis and management.CD20-negative diffuse large B-cell lymphomas: biology and emerging therapeutic options.EBV and HIV-Related LymphomaHIV/AIDS: epidemiology, pathophysiology, and treatment of Kaposi sarcoma-associated herpesvirus disease: Kaposi sarcoma, primary effusion lymphoma, and multicentric Castleman disease.Kaposi sarcoma-associated herpesvirus-encoded viral FLICE inhibitory protein (vFLIP) K13 cooperates with Myc to promote lymphoma in mice.Combination of arsenic and interferon-α inhibits expression of KSHV latent transcripts and synergistically improves survival of mice with primary effusion lymphomasKaposi sarcoma-associated herpesvirus (KSHV): molecular biology and oncogenesisβ-HHVs and HHV-8 in Lymphoproliferative Disorders.Functional p53 signaling in Kaposi's sarcoma-associated herpesvirus lymphomas: implications for therapy.Reactivation of the p53 pathway as a treatment modality for KSHV-induced lymphomas.Treatment of Kaposi sarcoma-associated herpesvirus-associated cancers.Therapeutic options for human herpesvirus-8/Kaposi's sarcoma-associated herpesvirus-related disorders.The radiological spectrum of pulmonary lymphoproliferative disease.Management of patients with HIV in the intensive care unitComparison of human herpes virus 8 related primary effusion lymphoma with human herpes virus 8 unrelated primary effusion lymphoma-like lymphoma on the basis of HIV: report of 2 cases and review of 212 cases in the literature.Extracavitary manifestation of primary effusion lymphoma as a right atrial mass.Contribution of viral and cellular cytokines to Kaposi's sarcoma-associated herpesvirus pathogenesisEmmprin and KSHV: new partners in viral cancer pathogenesis.Primary effusion lymphoma diagnosed by pericardiocentesis.Understanding pathogenetic aspects and clinical presentation of primary effusion lymphoma through its derived cell lines.Establishing and characterizing a new primary effusion lymphoma cell line harboring Kaposi's sarcoma-associated herpesvirus.Human herpes virus 8-unrelated primary effusion lymphoma-like lymphoma in a patient with hepatitis B virus-related liver cirrhosis: A case report.Use of cidofovir for the treatment of HIV-negative human herpes virus-8-associated primary effusion lymphoma.Therapeutic options for HIV-associated lymphomas.
P2860
Q26766493-DC8FB548-2F5E-4C1F-8B8E-147C128AD67EQ26775442-B1AF7E1F-0DC0-4AAC-AA0C-42E2F6FBE447Q26828791-391DF111-A512-4765-AE50-2FBF3E9422BEQ28544735-C0E2312B-18C6-4C17-8F2F-57437BFCF3FFQ30353137-651C5ED8-5BDC-4D93-9136-DE901F0ED37BQ30364647-9C5DC7AF-81D2-4BEF-A7C8-010F78D5F60FQ30379938-9EAA89D3-316B-4E57-B1FA-C40C94201444Q30408885-8DAA0405-EB9C-46E3-AA2F-5F19402A5F87Q30409463-8D5FF8B2-B218-4B1B-AE99-24D9F9031BCFQ30418735-01759212-337D-4B52-B5FC-9E8EEBB7BAEFQ33365218-EE6BAB7A-7FAF-4645-B7E3-9517EBC869AEQ33597377-EA9F591E-C07F-473A-86C3-1FAB4EBBF2C4Q33647573-1DB4F96A-FAD2-4F4A-999E-2657276D6F36Q34059058-3EFEF65B-D86B-4768-930F-20CD0E385E9CQ34103593-3971C4A5-2168-4F3D-8090-555390377E08Q34131954-356813F3-8240-492F-9C3E-5B0495638DADQ34390745-29893080-80F5-4891-BFF2-5096FC5C608DQ34460823-AB487ACD-4EDA-42F1-A3BD-6BE175C59A2AQ34549450-C1E06E0F-45AE-45B1-AF57-C6CFE3F065E0Q34597442-9FB6A0C6-D70B-48A5-AB9B-2D8600FD7914Q34616590-A4D08C4B-6899-482D-8278-4BE61756E23AQ35046691-DC286B72-A7FE-4E69-ABC5-D83D1D5F998AQ35127940-F74D24F1-89BF-49FE-B7A0-C89B8184F54CQ35560251-5F7F1BD8-45F7-44F8-917D-8E5EC90CE4B7Q35635426-597CD7D6-50F3-45B9-9CA0-D930BCB7A833Q35664106-4E0DFBC1-D157-4A3A-BB4B-D4DC58ED5F5FQ35895560-15A375D9-2F29-4C28-861A-1648CF73434BQ35917368-B8225AF6-CC1B-42F4-9C83-8B439766015DQ36325985-51D13655-FA67-43C0-9A0E-CA6CB1B4324CQ36403151-8AFC4549-BF5D-4149-95B7-56EC67C96A74Q36668747-36F97C76-B690-4A20-A52F-EE046E6967F5Q36744331-C52F1958-3DB8-4DE2-AB78-9DCC80AB84A0Q36882284-951C1B36-31F8-4971-81EF-C842CD17A26BQ37057685-58B0CD68-5FD9-4DB5-8D91-502C1FF3F8FFQ37061042-D6D1473E-93BF-420F-BF45-A97D4C3A1DF2Q37088015-B5AB17DD-18E1-42EA-B410-352D42E3D157Q37182325-6B22ED64-9CF6-473F-9957-64E489AF9352Q37723227-33C40459-ABB5-4B6D-9C01-56E20A4A2BA0Q37765465-9A17EFB2-5CF5-42C1-8CCC-5F2D890E761EQ37781368-73D7DE58-1CCE-415B-8962-A11704A4DAAF
P2860
Clinical features and outcome of primary effusion lymphoma in HIV-infected patients: a single-institution study.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Clinical features and outcome ...... s: a single-institution study.
@en
Clinical features and outcome ...... s: a single-institution study.
@nl
type
label
Clinical features and outcome ...... s: a single-institution study.
@en
Clinical features and outcome ...... s: a single-institution study.
@nl
prefLabel
Clinical features and outcome ...... s: a single-institution study.
@en
Clinical features and outcome ...... s: a single-institution study.
@nl
P2093
P50
P356
P1476
Clinical features and outcome ...... ts: a single-institution study
@en
P2093
Cecelia Simonelli
Emanuela Vaccher
Renato Talamini
Roberta Cinelli
Rosamaria Tedeschi
Umberto Tirelli
P304
P356
10.1200/JCO.2003.06.013
P407
P577
2003-11-01T00:00:00Z